M J Thomason1, D P Strachan. 1. Department of Public Health Sciences, St George's Hospital Medical School, London SW17 0RE, UK.
Abstract
BACKGROUND: Previous epidemiological studies have related mortality from chronic obstructive pulmonary disease (COPD) to forced expiratory volumes (FEV(1) or FEV(0.75)) and it is unknown whether other spirometric indices might have greater predictive power. METHODS: A case-control study of fatal COPD was conducted within a cohort of London civil servants who performed forced expiratory spirograms in 1967-9 and were followed up for mortality over 20 years. The spirograms of 143 men who died of COPD (ICD8 491, 492 or 519.8) were compared with those of 143 controls individually matched for age, height, and smoking habit who survived longer than their matched case. Flow rates in different parts of the spirogram were compared within case-control pairs and analysed as predictors of fatal COPD by conditional logistic regression. RESULTS: Within pair case:control ratios of FEV(1), mid expiratory flow rates (e.g. FEF(50-75)) and FEF(75-85) were highly intercorrelated (r>0.7) but correlations with FEF(85-95) were weaker (r<0.5). All indices except the FEV(1)/FVC ratio were stronger predictors of death from COPD within the first 10 years than of later deaths (15-19 years). After adjustment for FEV(1), mid expiratory flow rates independently predicted fatal COPD but end expiratory flow rates did not. The FEV(1) adjusted mortality ratios associated with a 10% decrement in each index were 2.24 (95% CI 1.54 to 3.76) for FEF(50-75), 1.20 (95% CI 1.00 to 1.42) for FEF(75-85), and 1.10 (95% CI 0.96 to 1.26) for FEF(85-95). CONCLUSION: This study confirms FEV(1) and mid expiratory flow rates as powerful predictors of mortality from COPD, and suggests that measurement of end expiratory flow rates would add little extra predictive information.
BACKGROUND: Previous epidemiological studies have related mortality from chronic obstructive pulmonary disease (COPD) to forced expiratory volumes (FEV(1) or FEV(0.75)) and it is unknown whether other spirometric indices might have greater predictive power. METHODS: A case-control study of fatal COPD was conducted within a cohort of London civil servants who performed forced expiratory spirograms in 1967-9 and were followed up for mortality over 20 years. The spirograms of 143 men who died of COPD (ICD8 491, 492 or 519.8) were compared with those of 143 controls individually matched for age, height, and smoking habit who survived longer than their matched case. Flow rates in different parts of the spirogram were compared within case-control pairs and analysed as predictors of fatal COPD by conditional logistic regression. RESULTS: Within pair case:control ratios of FEV(1), mid expiratory flow rates (e.g. FEF(50-75)) and FEF(75-85) were highly intercorrelated (r>0.7) but correlations with FEF(85-95) were weaker (r<0.5). All indices except the FEV(1)/FVC ratio were stronger predictors of death from COPD within the first 10 years than of later deaths (15-19 years). After adjustment for FEV(1), mid expiratory flow rates independently predicted fatal COPD but end expiratory flow rates did not. The FEV(1) adjusted mortality ratios associated with a 10% decrement in each index were 2.24 (95% CI 1.54 to 3.76) for FEF(50-75), 1.20 (95% CI 1.00 to 1.42) for FEF(75-85), and 1.10 (95% CI 0.96 to 1.26) for FEF(85-95). CONCLUSION: This study confirms FEV(1) and mid expiratory flow rates as powerful predictors of mortality from COPD, and suggests that measurement of end expiratory flow rates would add little extra predictive information.
Authors: R Peto; F E Speizer; A L Cochrane; F Moore; C M Fletcher; C M Tinker; I T Higgins; R G Gray; S M Richards; J Gilliland; B Norman-Smith Journal: Am Rev Respir Dis Date: 1983-09
Authors: Martin R Miller; Mikael Thinggaard; Kaare Christensen; Ole F Pedersen; Torben Sigsgaard Journal: Eur Respir J Date: 2014-01-31 Impact factor: 16.671
Authors: Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill Journal: Respir Med Date: 2010-03-03 Impact factor: 3.415
Authors: Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic Journal: Respir Med Date: 2019-08-09 Impact factor: 3.415
Authors: Jae Seung Lee; Seon Ok Kim; Joon Beom Seo; Ji-Hyun Lee; Eun Kyung Kim; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Sei Won Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee Journal: Lung Date: 2013-05-29 Impact factor: 2.584
Authors: Nicole Probst-Hensch; Ayoung Jeong; Daiana Stolz; Marco Pons; Paola M Soccal; Robert Bettschart; Deborah Jarvis; John W Holloway; Florian Kronenberg; Medea Imboden; Christian Schindler; Gianfranco F Lovison Journal: Front Public Health Date: 2021-05-11